New appointment at Recordati
This article was originally published in Scrip
Executive Summary
Dr Roland Rutschmann has been appointed vice-president and director for the special care and orphan drugs business at Recordati (Italy). He has also been appointed general manager of the company's fully owned subsidiary, Orphan Europe. Dr Rutschmann joins from Actelion, where he has served as head of strategic marketing, Europe, and general manager, Austria & Switzerland; general manager, Switzerland, Austria & EEMEA; and vice-president of emerging markets and geographical expansion. He has also worked at Roche, Schering-Plough and Warner Lambert.